KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC)

[at noodls] – April 6, 2013 · Results featured in the Innovations and Renewals session MONTE CARLO, MONACO, April 6, 2013 – KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim … more

View todays social media effects on KYTH

View the latest stocks trending across Twitter. Click to view dashboard

See who Kythera is hiring next, click here to view